{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:16:32Z","timestamp":1788128192658,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01452-5","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:48:35Z","timestamp":1785296915000},"page":"1138-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a"],"prefix":"10.1038","volume":"23","author":[{"given":"Xuru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"1452_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","volume":"18","author":"TE Keenan","year":"2020","unstructured":"Keenan TE, Tolaney SM. Role of immunotherapy in triple-negative breast cancer. J. Natl. Compr. Cancer. Netw. 2020;18:479\u201389.","journal-title":"J. Natl. Compr. Cancer. Netw"},{"key":"1452_CR2","doi-asserted-by":"crossref","unstructured":"Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int. J. Mol. Sci. 2021;22:5801.","DOI":"10.3390\/ijms22115801"},{"key":"1452_CR3","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"1452_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res. 2023;29:1009\u201316.","journal-title":"Clin Cancer Res"},{"key":"1452_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","volume":"27","author":"PM Galbo","year":"2021","unstructured":"Galbo PM, Zang X, Zheng D. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance. Clin. Cancer Res. 2021;27:2636\u201347.","journal-title":"Clin. Cancer Res"},{"key":"1452_CR6","doi-asserted-by":"crossref","unstructured":"Liu Y, Dong G, Yu J, Liang P. Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential. J. Transl. Med. 2025;23:198.","DOI":"10.1186\/s12967-025-06192-0"},{"key":"1452_CR7","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.7150\/thno.55074","volume":"11","author":"X Wan","year":"2021","unstructured":"Wan X, Guan S, Hou Y, Qin Y, Zeng H, Yang L, et al. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts. Theranostics. 2021;11:4975\u201391.","journal-title":"Theranostics"},{"key":"1452_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati L, Carradori G, Scherz-Shouval R. CAF-induced physical constraints controlling T-cell state and localization in solid tumors. Nat. Rev. Cancer. 2024;24:676\u201393.","journal-title":"Nat. Rev. Cancer"},{"key":"1452_CR9","doi-asserted-by":"publisher","first-page":"e1180485","DOI":"10.1080\/2162402X.2016.1180485","volume":"5","author":"M Zhou","year":"2016","unstructured":"Zhou M, Wen Z, Cheng F, Ma J, Li W, Ren H, et al. Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-kappaB signaling pathway. Oncoimmunology. 2016;5:e1180485.","journal-title":"Oncoimmunology"},{"key":"1452_CR10","doi-asserted-by":"crossref","unstructured":"Gao R, Ma J, Wen Z, Yang P, Zhao J, Xue M, et al. Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophils. OncoImmunology. 2018;7:e1438108.","DOI":"10.1080\/2162402X.2018.1438108"},{"key":"1452_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s40425-018-0452-5","volume":"6","author":"ZF Wen","year":"2018","unstructured":"Wen ZF, Liu H, Gao R, Zhou M, Ma J, Zhang Y, et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. J Immunother Cancer. 2018;6:151.","journal-title":"J Immunother Cancer"},{"key":"1452_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40425-019-0646-5","volume":"7","author":"YQ Chen","year":"2019","unstructured":"Chen YQ, Li PC, Pan N, Gao R, Wen ZF, Zhang TY, et al. Tumor-released autophagosomes induces CD4(+) T-cell-mediated immunosuppression via a TLR2-IL-6 cascade. J. Immunother Cancer. 2019;7:178.","journal-title":"J. Immunother Cancer"},{"key":"1452_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00262-020-02695-5","volume":"70","author":"T-Y Zhang","year":"2020","unstructured":"Zhang T-Y, Ren H-Y, Pan N, Dong H-X, Zhao S-M, Wen Z-F, et al. Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific na\u00efve CD8+ T-cell response and exhibit antitumor effect. Cancer Immunol Immunother. 2020;70:463\u201374.","journal-title":"Cancer Immunol Immunother"},{"key":"1452_CR14","doi-asserted-by":"crossref","unstructured":"Zhou X, Wu C, Wang X, Pan N, Sun X, Chen B, et al. Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis. J. ImmunoTherapy Cancer. 2024;12:e009082.","DOI":"10.1136\/jitc-2024-009082"},{"key":"1452_CR15","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s13402-024-00994-y","volume":"47","author":"X-r Wang","year":"2024","unstructured":"Wang X-r, Zhou X-h, Sun X-t, Shen Y-q, Wu Y-y, Wu C-d, et al. Tumor cell-released autophagosomes promote lung metastasis by upregulating PD-L1 expression in pulmonary vascular endothelial cells in breast cancer. Cell Oncol. 2024;47:2147\u201362.","journal-title":"Cell Oncol"},{"key":"1452_CR16","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1111\/cas.15507","volume":"113","author":"X Sun","year":"2022","unstructured":"Sun X, Wang X, Yan C, Zheng S, Gao R, Huang F, et al. Tumor cell-released LC3-positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation. Cancer Sci. 2022;113:3405\u201316.","journal-title":"Cancer Sci"},{"key":"1452_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T-cell homeostasis and mediates effector differentiation. Immunity. 2013;39:1143\u201357.","journal-title":"Immunity"},{"key":"1452_CR18","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1046\/j.1432-1327.1999.00145.x","volume":"259","author":"B Turk","year":"1999","unstructured":"Turk B, Dolenc I, Lenarcic B, Krizaj I, Turk V, Bieth JG, et al. Acidic pH as a physiological regulator of human cathepsin L activity. Eur J Biochem. 1999;259:926\u201332.","journal-title":"Eur J Biochem"},{"key":"1452_CR19","doi-asserted-by":"crossref","unstructured":"Wang S, Hou K, Gui S, Ma Y, Wang S, Zhao S, et al. Insulin-like growth factor 1 in heat stress-induced neuroinflammation: novel perspective about the neuroprotective role of chromium. Stress Biol. 2023;3:23.","DOI":"10.1007\/s44154-023-00105-1"},{"key":"1452_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302613","volume":"10","author":"C Li","year":"2023","unstructured":"Li C, Chen T, Liu J, Wang Y, Zhang C, Guo L, et al. FGF19-induced inflammatory CAF promoted neutrophil extracellular trap formation in the liver metastasis of colorectal cancer. Adv Sci (Weinh). 2023;10:e2302613.","journal-title":"Adv Sci (Weinh)"},{"key":"1452_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer. 2020;20:174\u201386.","journal-title":"Nat. Rev. Cancer"},{"key":"1452_CR22","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-22-3034","volume":"83","author":"G Davidson","year":"2023","unstructured":"Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, et al. Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma. Cancer Res. 2023;83:2952\u201369.","journal-title":"Cancer Res"},{"key":"1452_CR23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10:1330\u201351.","journal-title":"Cancer Discov"},{"key":"1452_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12:620\u201338.","journal-title":"Theranostics"},{"key":"1452_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41571-025-01035-9","volume":"22","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zhao H, Yang W, Zhang L. The next generation of immunotherapies for lung cancers. Nat. Rev. Clin. Oncol. 2025;22:592\u2013616.","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"1452_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S1470-2045(24)00379-6","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, He Y, Wang W, Cai Q, Ge F, Chen Z, et al. Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis. Lancet Oncol. 2024;25:1347\u201356.","journal-title":"Lancet Oncol"},{"key":"1452_CR27","doi-asserted-by":"crossref","unstructured":"Jin M, Fang J, Peng J, Wang X, Xing P, Jia K, et al. PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol Cancer. 2024;23:266.","DOI":"10.1186\/s12943-024-02176-8"},{"key":"1452_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan Y, Sun D, Hu J, Chen Y, Sun L, Yu H, et al. Multiomic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small cell lung cancer. Nat Genet. 2025;57:126\u201339.","journal-title":"Nat Genet"},{"key":"1452_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-025-03260-6","volume":"134","author":"T Borisov","year":"2026","unstructured":"Borisov T, Metodiev D, Ferdinandov D, Roumenina LT. Complement system in tumor growth and metastases. Br J Cancer. 2026;134:185\u201394.","journal-title":"Br J Cancer"},{"key":"1452_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2024.101921","volume":"77","author":"D Ajona","year":"2025","unstructured":"Ajona D, Cragg MS, Pio R. The complement system in clinical oncology: applications, limitations and challenges. Semin Immunol. 2025;77:101921.","journal-title":"Semin Immunol"},{"key":"1452_CR31","doi-asserted-by":"publisher","unstructured":"Subramanian AK, Java A, Gupta SK, Gupta S, Bomback AS. Strategies to mitigate infection risk in patients receiving complement inhibitor therapy. Clin Infect Dis. 2026;ciag081. https:\/\/doi.org\/10.1093\/cid\/ciag081.","DOI":"10.1093\/cid\/ciag081"},{"key":"1452_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","volume":"403","author":"EE West","year":"2024","unstructured":"West EE, Woodruff T, Fremeaux-Bacchi V, Kemper C. Complement in human disease: approved and up-and-coming therapeutics. Lancet. 2024;403:392\u2013405.","journal-title":"Lancet"},{"key":"1452_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","volume":"24","author":"DC Mastellos","year":"2024","unstructured":"Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity. Nat Rev Immunol. 2024;24:118\u201341.","journal-title":"Nat Rev Immunol"},{"key":"1452_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cels.2021.04.005","volume":"12","author":"D DeTomaso","year":"2021","unstructured":"DeTomaso D, Yosef N. Hotspot identifies informative gene modules across modalities of single-cell genomics. Cell Syst. 2021;12:446\u201356.e449.","journal-title":"Cell Syst"},{"key":"1452_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma Y-A, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods. 2017;14:309\u201315.","journal-title":"Nat. Methods"},{"key":"1452_CR36","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell\u2013cell communication from combined expression of multisubunit ligand\u2013receptor complexes. Nat. Protoc. 2020;15:1484\u2013506.","journal-title":"Nat. Protoc"},{"key":"1452_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107628","volume":"31","author":"S Davidson","year":"2020","unstructured":"Davidson S, Efremova M, Riedel A, Mahata B, Pramanik J, Huuhtanen J, et al. Single-cell rna sequencing reveals a dynamic stromal niche that supports tumor growth. Cell Rep. 2020;31:107628.","journal-title":"Cell Rep"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01452-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01452-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:02:23Z","timestamp":1788127343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01452-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01452-5","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Welfare Committee of Southeast University (Approval No. 20250220670) and were performed in accordance with its animal welfare guidelines. All human specimens were approved by the Ethics Committee of Jiangsu Cancer Hospital (Approval No. KY-2024-114), and the study was conducted in accordance with relevant ethical standards and research protocols.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}